meningitis final november 4
TRANSCRIPT
-
8/14/2019 MENINGITIS Final November 4
1/64
-
8/14/2019 MENINGITIS Final November 4
2/64
PROMPT recognition of Meningitis Rapid Diagnostic testing to identify the
etiologic pathogen and adjust therapy Rapid Initiation of appropriate Empiric
Antimicrobial therapy Targeted Antimicrobial therapy Dos and Donts for the Boards
-
8/14/2019 MENINGITIS Final November 4
3/64
-
8/14/2019 MENINGITIS Final November 4
4/64
-
8/14/2019 MENINGITIS Final November 4
5/64
1805-1900s: ~100% fatal 1913: Flexner: intrathecal meningococcal
antiserum. Prevented some deaths 1930s: Antibiotics. Improved survival Current data:
Adults: 25% mortality, 21-28% neurologic
sequelaeBacterial meningitis remains a
medical emergency!
-
8/14/2019 MENINGITIS Final November 4
6/64
RECOGNIZE Clinical picture is often unimpressivewhen the patient is first seen
aLTERED mENTAL sTATUS
FEVER HEADACHE
URIinterruptedby one of the
meningeal
symptoms:vomiting,
headache,
lethargy,
confusion, stiffneck
-
8/14/2019 MENINGITIS Final November 4
7/64
1. AGE 2.SEASON 3.Geography 4.Predisposing factors
(immunocompromised state; basilar skullfracture with CSF leak; head trauma; post
neurosurgical procedures ~wound and FB) 5.Onset and duration of illness (acute;
subacute and chronic) ~community aquiredor nosocomial
-
8/14/2019 MENINGITIS Final November 4
8/64
6.Travel,occupational and recreationalexposures( insect and animal contact)
7. Vaccination history and current meds (ABX) 8.Parameningeal foci or septic emboli from IE 9. Imaging before Lumbar puncture 10. Gram stain and Interpretation of the CSF
formula
-
8/14/2019 MENINGITIS Final November 4
9/64
14-year-old male with no significant PMH isadmitted to the hospital with acute onset ofhigh fever, chills, sore throat, stiff neck, and
lethargy T 1040F, P 120, RR 32, BP 70/30 mmHg On examination, he was oriented only to person, and had evidence of nuchal rigidity WBC 25,000/mm3with 20% bands CSF WBC 1,500/mm3(98% neutrophils), glucose
20 mg/dL, and protein 200 mg/dL
-
8/14/2019 MENINGITIS Final November 4
10/64
A Haemophilus influenzae type b B Neisseria meningitidis C Streptococcus pneumoniae D Enterovirus 71 E Cryptococcus neoformans
-
8/14/2019 MENINGITIS Final November 4
11/64
-
8/14/2019 MENINGITIS Final November 4
12/64
LOOK @ AGE/ARMYRECRUITS/COLLEGE
STUDENTS/Rash
-
8/14/2019 MENINGITIS Final November 4
13/64
Affects mostly children and young adults; mortality 3-13% (SPORADIC 98% cases B) Epidemics usually caused by serogroups A and C Group Y strains associated with pneumonia Serogroup C disease increasing in the US Nasopharyngeal acquisition of infection Predisposition in those with congenital
deficiencies in terminal complementcomponents (C5-C9) and properdindeficiencies
-
8/14/2019 MENINGITIS Final November 4
14/64
PEN G and AMPICILLIN are DRUGS OFCHOICE
Empiric therapy with Third GenerationCephalosporins recommended
Nasopharyngeal carrier state 10 to 15%
Infection control DROPLET precautions~surgical mask
-
8/14/2019 MENINGITIS Final November 4
15/64
21-year-old male without significant PMH was founddifficult to arouse by his roommate in his collegedormitory. Patient taken via fire rescue to ER
On exam, he was lethargic, febrile to 1030
F,tachycardic, tachypnec, and hypotensve. His neckwas stiff and he had a petechial rash on the lowerextremities
CSF revealed a neutrophilic pleocytosis, low glucose,and elevated protein. Grams stain showed gram-negative diplococci
The patient received IV penicillin G and made a fullrecovery. Blood and CSF grew Neisseria meningitidis
-
8/14/2019 MENINGITIS Final November 4
16/64
For which of the following persons isantimicrobial chemoprophylaxis
recommended? The Dean of the college The ambulance driver The emergency room physician The triage nurse The patient
-
8/14/2019 MENINGITIS Final November 4
17/64
Household members Day care center contacts Persons directly exposed to patients oral
secretions - kissing, mouth-to-mouthresuscitation - endotracheal intubation or endotracheal tube
management Index patient if not treated with a third
generation cephalosporin Chemoprophylactic regimens - rifampin - ceftriaxone - ciprofloxacin - azithromycin
-
8/14/2019 MENINGITIS Final November 4
18/64
-
8/14/2019 MENINGITIS Final November 4
19/64
Immunocompromised
patients H/O CNS disease
New onset SEIZURE Focal neurological
signs Altered consciousness
Papilledema
Delay in performing LP
Do Blood Cx STAT Dexamethasone and
empiric antimicrobials CT scan
LP if CT negative
-
8/14/2019 MENINGITIS Final November 4
20/64
Normal Bacterial Viral TBCells 0-5 >1000
-
8/14/2019 MENINGITIS Final November 4
21/64
Gram stain Positive in 60-90%
Culture CSF Positive in 70-85%**
Blood Culture Positive in 50%
** Beware of partially treated meningitis with abx for2-3 days this may give you negative Cx although CSFremains abnormal; Shift from PMN to polys andlymphs or lymphocytic predominance
Do NOT assume this is NOT a bacterial infection
-
8/14/2019 MENINGITIS Final November 4
22/64
Gram negative:Diplococci: Meningococcus
Bacilli: E. coli
Coccobacilli: H influenzae(small, pleomorphic)
Gram Positive:
Diplococci: Pneumococcus
Chains: Strep Group B
Clusters: Staph
Rods & cocobacilli: Listeria
-
8/14/2019 MENINGITIS Final November 4
23/64
56-year-old female with a 2-day history offever, chills, headache, and confusion. Sawher physician 5 days earlier with complaintsof earache; received ciprofloxacin
T 1030F, P 140, RR 32, BP 90/60 mmHg Obtunded, stiff neck, purpuric rash on lower
extremities CSF showed opening pressure of 280 mm
H2O, WBC 2,500/mm3(99% neutrophils),glucose 15 mg/dL, protein 400 mg/dL
-
8/14/2019 MENINGITIS Final November 4
24/64
-
8/14/2019 MENINGITIS Final November 4
25/64
Which of the following regimens should beinitiated?
A Dexamethasone + Penicillin G B Dexamethasone + Ceftriaxone C Dexamethasone + Vancomycin + Ampicillin D Dexamethasone + Vancomycin +
Ceftriaxone E Vancomycin + Ceftriaxone
-
8/14/2019 MENINGITIS Final November 4
26/64
Most common etiologic agent in US Mortality of 19-26%
Associated with other suppurative foci ofinfection ~ Pneumonia (25%) Otitis media or mastoiditis (3 0%) Sinusitis (10-15%) Endocarditis (
-
8/14/2019 MENINGITIS Final November 4
27/64
PCN MIC g/ml Antimicrobial therapy
1.0 Vancomycin + third generationcephalosporin*
>2.0 Vancomycin + third generationcephalosporin **
*Cefotaxime or ceftriaxone
!! REMEMBER SUSCEPTIBILITIES ARENOT ROUTINELY DONE
**Consider addition of Rifampin ifCeftriaxone MIC > 2
-
8/14/2019 MENINGITIS Final November 4
28/64
-
8/14/2019 MENINGITIS Final November 4
29/64
Microorganism Antimicrobial Therapy S. pneumoniae Vancomycin + a third generation cephalosporina,b
N. meningitidis Penicillin G, ampicillin, or a third generation cephalosporina
H. influenzae type b Third generation cephalosporina
L. monocytogenes Ampicillin or penicillin G*
S. agalactiae Ampicillin or penicillin G*
E. coli Third generation cephalosporina
acefotaxime or ceftriaxone
baddition of rifampin may be considered, especially if dexamethasone given
*addition of an aminoglycoside may be considered
-
8/14/2019 MENINGITIS Final November 4
30/64
Attenuates subarachnoid space inflammatory response resulting fromantimicrobial-induced lysis
Recommended for infants and children with Haemophilus influenzaetype b meningitis and considered for pneumococcal meningitis in
childhood, if commenced with or before parenteral antimicrobialtherapy
Clinical trials (predominantly in infants and children) have demonstratedreduction in neurologic and/or audiologic sequelae
Recommended in adults with pneumococcal meningitis
Administer at 0.15 mg/kg every 6 hours for 2-4 days concomitant with orjust before first antimicrobial dose
-
8/14/2019 MENINGITIS Final November 4
31/64
Tuberculous Meningitis Corticosteroids (extreme neurologic
compromise, elevated ICP, impending
herniation, impending or established spinalblock;
CT/MR evidence of hydrocephalus or basilarmeningitis)
Cryptococcal MeningitisReduction in intracranial pressure (frequenthigh- volume lumbar punctures, VP shunts)
-
8/14/2019 MENINGITIS Final November 4
32/64
60-year-old male with acute myelogenous leukemiapresented with fever, headache, ataxia, and alteredmental status. Recently traveled to an outdoor familypicnic in rural Virginia. He is allergic to penicillin
(anaphylaxis) T 102oF, P 120, RR 24, BP 100/60 On examination, he was obtunded and had nuchal
rigidity. Funduscopic exam revealed no papilledema.Babinski responses were positive bilaterally
WBC was 25,000/mm3(30% bands) LP revealed a WBC 1500/mm3(50 neutrophils, 50%
lymphocytes), glucose 30 mg/dL, and protein 200mg/dL
-
8/14/2019 MENINGITIS Final November 4
33/64
Which of the following antimicrobialregimens should be initiated?
A Vancomycin administered intravenouslyand intrathecally B Vancomycin + rifampin C Chloramphenicol D Trimethoprim-sulfamethoxazole E Erythromycin
-
8/14/2019 MENINGITIS Final November 4
34/64
http://upload.wikimedia.org/wikipedia/commons/c/c9/Enterococcus_histological_pneumonia_01.png -
8/14/2019 MENINGITIS Final November 4
35/64
Mortality 15-29% Rare cause of bacterial meningitis in US (8%) Outbreaks associated with consumption of
contaminatedcoleslaw, raw vegetables, milk,cheese, processed meats Common in neonates (~20% of cases) Disease in adults associated with: Elderly Alcoholism Malignancy Immune suppression Diabetes mellitus Hepatic and renal disease Iron overload Collagen-vascular disorders
-
8/14/2019 MENINGITIS Final November 4
36/64
CASE #2 46-year-old male executive from Phoenix,Arizona
presents to the ER with recent history of going on acruise to Jamaica. One week after returning, he
developed headaches, stiff neck, and vomiting. He had no significant PMH and was sexually active
with multiple partners. Physical exam revealed low-grade fever and
meningismus, but was otherwise negative. CSF examination revealed a WBC count of 300/mm3
with 60% eosinophils, glucose of 45 mg/dL andprotein 150 mg/dL.
Gram stain was negative.
-
8/14/2019 MENINGITIS Final November 4
37/64
Which of the following is the most likelycause of this patients illness?
Treponema pallidum Mycobacterium tuberculosis Coccidioides immitis Angiostrongylus cantonensis Lymphoma
-
8/14/2019 MENINGITIS Final November 4
38/64
Most common cause of eosinophilic meningitis
Reported from many countries of the world (Thailand,Malaysia, Vietnam, Indonesia, Papua New Guinea,
Taiwan, Pacific Islands); recent outbreak in Jamaica Rat infection rate in urban Bangkok ~40% May spread as rats move freely from port to port on ships Symptoms begin 6-30 days after ingestion of raw
mollusks or other sources of the parasite.
Clinical findings are headache (90%), stiff neck (56%),paresthesias (54%), and vomiting (56%) CSF reveals a moderate pleocytosis with 16-72%
eosinophils; larvae are occasionally found in CSF
-
8/14/2019 MENINGITIS Final November 4
39/64
Usually self limited course and recover
completely
Analgesics
Corticosteroids
Frequent but careful LPs if increasedintracranial pressure
-
8/14/2019 MENINGITIS Final November 4
40/64
May present acutely, although usually subacute tochronic
Patients generally complain of headache, low-gradefever, weight loss, and mental status changes;
signs of meningeal irritation are usually absent Serumcomplement-fixing antibody titers >1:32 to
1:64 suggest disseminated disease CSF examination may occasionally reveal a prominent
eosinophilia; CSF protein is almost always elevated Only 25-50% of patients have positive CSF cultures CSFcomplement-fixing antibodies present in at least
70% of cases; titers parallel course of meningealdisease
-
8/14/2019 MENINGITIS Final November 4
41/64
60 year old male with ESRD immigrated fromBrazil to US and underwent a cadaveric renaltransplant. Prior to transplant, he had
recurrent epigastric pain. WBC 6,500 with 15% eosinophils After transplant received Prednisone and
Azathioprine Presented 1 month later with T 39C,headache, meningismus and altered mentalstatus
-
8/14/2019 MENINGITIS Final November 4
42/64
Lumbar puncture showed
WBC 2500/mm
(98% neutrophils) Glucose 20 mg/dl
Protein 450mg/dl Placed on Empiric Vancomycin, Ampicillin
and Ceftriaxone
Blood cultures and CSF Cx grew E.coli
-
8/14/2019 MENINGITIS Final November 4
43/64
Which of the following diagnostic test wouldmost likely establish the pathogenesis ofE.colimeningitis in this patient?
A. CT scan of the head and sinuses B. Bronchoscopy with transbronchial lung
biopsy C. Serial stool examinations D. Meningeal Biopsy E. Metrizimide cisternography
-
8/14/2019 MENINGITIS Final November 4
44/64
Klebsiella species, Escherichia coli, Serratiamarcescens, Pseudomonas aeruginosa,Salmonella species
Isolated from CSF of patients following headtrauma or neurosurgical procedures
Cause meningitis in neonates, the elderly,immunocompromised patients, and in patients
with gram- negative septicemia Associated with disseminated strongyloidiasis
in the hyperinfection syndrome
-
8/14/2019 MENINGITIS Final November 4
45/64
An 80-year-old male is brought to the hospital by hisfamily because of personality changes and olfactoryhallucinations
On exam, T 1010
F, P 90, RR 16, BP 120/90 mmHg He is confused and oriented only to person. There is
no meningimus or evidence of focal neurologicdeficits
CT of head without contrast is negative; CSF reveals aWBC of 90/mm3(95% lymphocytes), glucose of 80mg/dL (serum 100 mg/dl), and protein of 70 mg/dL
-
8/14/2019 MENINGITIS Final November 4
46/64
Which of the following is the best test forestablishing the diagnosis in this patient?
A Electroencephalogram B MRI of head with gadolinium C Brain biopsy D CSF polymerase chain reaction E CSF antibody studies
-
8/14/2019 MENINGITIS Final November 4
47/64
50-year-old man evaluatedfor obtundation and fever
Brain MRI with gadoliniumreveals swelling and
enhancement of the lefttemporal lobe; CSFanalysis reveals a WBC of10/mm3, normal glucoseand elevated protein
Intravenous acyclovir isinitiated CSF PCR for HSV 1 and
HSV 2 are negative
-
8/14/2019 MENINGITIS Final November 4
48/64
Which of the following is the appropriatemanagement for this patient?
A. Discontinue acyclovir B. Perform a brain biopsy C. Begin ganciclovir + foscarnet D. Send CSF for HHV6 PCR E. Perform HSV PCR on a new CSF specimen
-
8/14/2019 MENINGITIS Final November 4
49/64
Neuroimaging MRI is procedure of choice (AFTER LP)
Edema and hemorrhage in temporal lobesBilateral temporal lobes (pathognomonic) CSF Analysis Lymphocytes, increased protein, normal
glucose Polymerase chain reaction EEG Periodic lateralizing epileptiform discharges
-
8/14/2019 MENINGITIS Final November 4
50/64
Published reports have found that falsenegatives can occur due to testing
Too early or too late,
improper sample transport, or low volumes of CSF tested. HSVE is frequently fatal untreated. Therefore, if
MRI shows compatible temporal lobe findingsand no alternative diagnosis is established,
continued treatment with acyclovir should bestrongly considered.
A second spinal tap with repeat CSF PCR or abrain biopsy may be indicated.
-
8/14/2019 MENINGITIS Final November 4
51/64
75 year old woman from Colorado presentswith acute onset of altered mental status and
fever Neurological examination reveals bilateral
tremors of theextremities and cogwheelrigidity
Brain MRI reveals T1 hypodense lesions in thethalamus and basal ganglia that arehyperintense on T2 images
-
8/14/2019 MENINGITIS Final November 4
52/64
CSF Analysis reveals a WBC of 300/mmglucose of 70 and protein of 105.
Which of the following tests is most likely toconfirm the diagnosis in this patient?
A. Serum Ig M antibody
B. Serum Ig G antibody C. CSF IgM antibody D. CSF PCR E. Brain Biopsy
-
8/14/2019 MENINGITIS Final November 4
53/64
First US cases reported in 1999 in New YorkCity
Birds are main reservoirs Transmission
-mosquito vector
-transfusion
-transplantation
-Breast feeding
-
8/14/2019 MENINGITIS Final November 4
54/64
Age >50 years~ increased incidence 1/150 develop neuroinvasive disease Tremors and Myoclonus Parkinsonism Poliomyelitis like flaccid paralysis Serum IgM and IgG capture ELISA
(cross reactivity with otherflaviviruses)
CSF IgM antibodies (diagnostic ofneuroinvasive disease)
CSF PCR (positive in
-
8/14/2019 MENINGITIS Final November 4
55/64
Etiologies of Viral
encephalitis
THERAPY FOR ENCEPHALITIS Etiology Therapy HSV Acyclovir VZV Acyclovir CMV Ganciclovir + foscarnet HHV-6 Ganciclovir or
foscarnet HIV HAART JC virus HAART
Echo virusCoxsakie and
EnterovirusesHerpes SimplexWest Nile virus
Un identified etiology32- 75%
Herpes Encephalitisis
NOT SEASONALsporadic
**Clues !!!epidemiological
factors
-
8/14/2019 MENINGITIS Final November 4
56/64
56 year old man s/p Kidney transplant in 2006s/p Left mastectomy for a painful mass onSept 1st 2009 discharged POD # 3
re-admitted a week later with urinaryretention and rectal bleeding.
Unclear cause of urinary retention relieved
after foley catheter insertion Rectal bleeding attributed to constipationand a bowel regimen ordered by generalsurgery
-
8/14/2019 MENINGITIS Final November 4
57/64
Day 4 of admission patient began to have somehallucinations and beginning confusion.
Agitation increased gradually over the next few
days. CT Brain No acute abnormality MRI ( X AICD ) Day 7 after admission; after a bowel movement
patient is turned back to supine position turnsgray codes and is intubated ( ?Aspiration)
Day 14 ID is consulted for a persistent fever onVancomycin and Cefepime with a RLLPneumonia
-
8/14/2019 MENINGITIS Final November 4
58/64
Patient was on Haldol round the clock forsevere agitation attributed to ICUdelirium..initially sleep deprivation
WHAT ARE WE MISSING?
Fever, altered mental statusin an Immuno-compromised host ???????CONFOUNDERS pneumonia with
Achromobacter Xylosoxidans I to cefepime
-
8/14/2019 MENINGITIS Final November 4
59/64
Noninvasive testing was ordered and so wasand LP
Serum Cryptococcal Antigen was 1:1024!!!! CSF CrAG was 1:2084 Protein was 594 Glucose was 37 CSF wbc Neutrophils Lymphocytes
-
8/14/2019 MENINGITIS Final November 4
60/64
Patient was initiated on High doseFluconazole and 5 Flucytosine withoutreversal of neurological status.
He underwent trach and peg and died 2weeks after initiation of therapy.
-
8/14/2019 MENINGITIS Final November 4
61/64
-
8/14/2019 MENINGITIS Final November 4
62/64
CSF parameter NON AIDS(%) AIDS(%)
Blood cultures - 30- 63%
Serum CrAG 66% 99%
Opening pressure>200 mmH2O
72% 62- 66%
CSF Glucose < 40mg/dl 73% 33%
CSF protein>45mg/dl 89% 58%
CSF Leukocytes > 20/mm 70% 13 -31%
CSF Culture 96% 95%
CSF CrAG 86% 91-100%
-
8/14/2019 MENINGITIS Final November 4
63/64
Septic Emboli with Infective Endocarditis Brain Abscess Secondary Syphilis Parameningeal focus
Rocky mountain Spotted fever ~ Doxycycline Aspetic Meningitis like picture Leptospirosis~ water rodent exposure Hepatitis/ meningitis
LYME disease
Lymphocytic choriomeningitis ~grip like illness Influenza like
2000-3000 lymphocytes / winter peak Mumps~ peaks in winter with orchitis and parotitis
Brucellosis Midline tumors craniopharyngiomas MEDS NSAIDs ( afebrile)
-
8/14/2019 MENINGITIS Final November 4
64/64
Tunkel AR, Hartman BJ, Kaplan SL, et al.Practice guidelines for the management ofbacterial meningitis. Clin Infect Dis2004;39:11267-84.
Spanos A, Harrell FE Jr, Durack DT.Differential diagnosis of acute meningitis:
an analysis of the predictive value of initialobservations. JAMA 1989;262:2700-7.